Skip to main content
SpringerLink
Log in

Use of norfloxacin for prevention of symptomatic urinary tract infection in chronically catheterized patients

  • Notes
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

Thirty-four elderly inpatients with long-term urethral catheters were randomly assigned to receive either norfloxacin (200 mg/day) or placebo in a double-blind study with cross-over after three months. Twenty-three patients completed the entire study. Norfloxacin treatment was associated with a persistent decrease in gram-negative isolates (p<0.005) and the acquisition of gram-positive norfloxacin-resistant flora. It also resulted in a highly statistically significant reduction of symptomatic urinary tract infections (1 vs. 12, p<0.02), a decrease in catheter-associated local complications, obstructions and leakage (p<0.05) and an improvement in the patients' general condition (p<0.001). In conclusion, within the conditions of the present study, long-term suppression of gramnegative bacteriuria by norfloxacin reduced the incidence of catheter-related urinary tract infection and associated morbidity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Warren JW, Steinberg L, Hebel JR, Tenney JH: The prevalence of urethral catheterization in Maryland nursing homes. Archives of Internal Medicine 1989, 149: 1535–1537.

    PubMed  Google Scholar 

  2. Platt R, Polk BF, Murdock B, Rosner B: Mortality associated with nosocomial urinary-tract infection. New England Journal of Medicine 1982, 307: 637–642.

    PubMed  Google Scholar 

  3. Stark RP, Maki DG: Bacteriuria in the catheterized patient. What quantitative level of bacteriuria is relevant? New England Journal of Medicine 1984, 311: 560–564.

    PubMed  Google Scholar 

  4. Breitenbucher RB: Bacterial changes in the urine samples of patients with long-term indwelling catheters. Archives of Internal Medicine 1984, 144: 1585–1588.

    PubMed  Google Scholar 

  5. Warren JW, Anthony WC, Hoopes JM, Muncie HL: Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients. Journal of the American Medical Association 1982, 248: 454–458.

    PubMed  Google Scholar 

  6. Britt MR, Garibaldi RA, Miller WA, Herbertson RM, Burke JP: Antimicrobial prophylaxis for catheter-associated bacteriuria. Antimicrobial Agents and Chemotherapy 1977, 11: 240–243.

    PubMed  Google Scholar 

  7. Mountokalakis T, Skounakis M, Tselentis J: Short-term versus prolonged systemic antibiotic prophylaxis in patients treated with indwelling catheters. Journal of Urology 1985, 134: 506–508.

    PubMed  Google Scholar 

  8. Brocklehurst JC, Brocklehurst S: The management of indwelling catheters. British Journal of Urology 1978, 50: 102–105.

    PubMed  Google Scholar 

  9. Cutajar CL: Norfloxacin prophylaxis for endoscopic urological surgery. British Journal of Urology 1992, 69: 421–424.

    PubMed  Google Scholar 

  10. Vollaard EJ, Clasener HA, Zambon JV, Joosten HJ, van Griethuysen AJ: Prevention of catheter-associated gramnegative bacilluria with norfloxacin by selective decontamination of the bowel and high urinary concentration. Journal of Antimicrobial Chemotherapy 1989, 23: 915–922.

    PubMed  Google Scholar 

  11. van der Wall E, Verkooyen RP, Mintjes-de Groot J, Oostinga J, van Dijk A, Hustinx WNM, Verbrugh HA: Prophylactic ciprofloxacin for catheter-associated urinary-tract infection. Lancet 1992, 339: 946–951.

    PubMed  Google Scholar 

  12. Cochran WG, Cox DR: Experimental designs. John Wiley & Sons, New York, 1975.

    Google Scholar 

  13. Schaeffer AJ: Catheter-associated bacteriuria. Urologic Clinics of North America 1986, 13: 735–747.

    PubMed  Google Scholar 

  14. Wang C, Sabbaj J, Corrado M, Hoagland V: World-wide clinical experience with norfloxacin: efficacy and safety. Scandinavian Journal of Infectious Diseases 1986, Supplement 48: 81–89.

    PubMed  Google Scholar 

  15. Warren JW, Damron D, Tenney JH, Hoopes JM, Deforge B, Muncie HL: Fever, bacteremia, and death as complications of bacteriuria in women with long-term urethral catheters. Journal of Infectious Diseases 1987, 155: 1151–1158.

    PubMed  Google Scholar 

  16. Verbrugh HA, Mintjes-de Groot AJ, Andriesse R, Hamersma K, van Dijk A: Postoperative prophylaxis with norfloxacin in patients requiring bladder catheters. European Journal of Clinical Microbiology & Infectious Diseases 1988, 7: 490–494.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Infectious Diseases, University Hospital, CH-1211, Geneva 14, Switzerland

    O. T. Rutschmann

  2. Department of Medicine, Hôpital de Zone de Saint-Loup/Orbe, CH-1318, Pompaples, Switzerland

    A. Zwahlen

Authors
  1. O. T. Rutschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Zwahlen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rutschmann, O.T., Zwahlen, A. Use of norfloxacin for prevention of symptomatic urinary tract infection in chronically catheterized patients. Eur. J. Clin. Microbiol. Infect. Dis. 14, 441–444 (1995). https://doi.org/10.1007/BF02114901

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02114901

Keywords

Search

Navigation